PMN
PROMIS NEURSCNC (PMN)
NASDAQ
$10.30+$0.65 (+6.76%)
Price as of Jun 03, 2026 7:56 PM EDT
  • $96.9M
    Market Cap
  • -17.14%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-33.4M
+213.78%
-10.6M
+34.95%
-7.9M
-51.00%
-16.1M
N/A
Depreciation and Amortization Expense
N/A
N/A
20,838
0.00%
20,838
+310.84%
5,072
N/A
Total Operating Expenses
40.2M
+138.70%
16.8M
+17.98%
14.3M
-39.00%
23.4M
N/A
Operating Profit
-40.2M
+138.70%
-16.8M
+17.98%
-14.3M
-39.00%
-23.4M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-76,775
0.00%
-76,775
-61.88%
-201,390
-28.60%
-282,064
N/A
Interest Income and Expense and Net
-76,775
0.00%
-76,775
-61.88%
-201,390
-28.60%
-282,064
N/A
Total Nonoperating Income and Expense
448,161
-97.71%
19.6M
+1,766.83%
1.1M
-80.25%
5.3M
N/A
Income before Taxes
-40.2M
+138.70%
-16.8M
+17.98%
-14.3M
-39.00%
-23.4M
N/A
Income Taxes
N/A
N/A
0
N/A
0
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-39.7M
-1,529.33%
2.8M
+121.03%
-13.2M
-26.85%
-18.1M
N/A
Net Income from Continuing Operations Applicable to Common
-39.7M
-1,529.33%
2.8M
+121.03%
-13.2M
-26.85%
-18.1M
N/A
Basic EPS and Net Income
-22.61
-20,654.55%
0.11
+110.28%
-1.07
-55.60%
-2.41
N/A
Diluted EPS and Net Income
-22.61
-20,654.55%
0.11
+110.28%
-1.07
-55.60%
-2.41
N/A
Basic Weighted Average Shares
1.8M
-93.22%
25.9M
+110.86%
12.3M
+63.85%
7.5M
N/A
Diluted Weighted Average Shares
1.8M
-93.36%
26.5M
+115.26%
12.3M
+63.85%
7.5M
N/A
Balance Sheet
Cash and Cash Equivalents
6.1M
-53.98%
13.3M
+5.50%
12.6M
+114.41%
5.9M
N/A
Short-Term Investments
33,753
+2.12%
33,051
+2.14%
32,358
+4.35%
31,009
N/A
Cash and Cash Equivalents and Short-Term Investments
6.2M
-53.84%
13.3M
+5.49%
12.6M
+113.83%
5.9M
N/A
Total Current Assets
9.2M
-51.45%
18.9M
+38.86%
13.6M
+97.28%
6.9M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
80,000
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
321
0.00%
321
N/A
Total Long-Term Assets
32,000
N/A
0
-100.00%
321
0.00%
321
N/A
Total Assets
9.2M
-51.45%
18.9M
+38.86%
13.6M
+96.68%
6.9M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
10.4M
+369.33%
2.2M
-76.27%
9.3M
+45.79%
6.4M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
0
-100.00%
3.9M
N/A
Total Long-Term Liabilities
5,592
0.00%
5,592
-99.80%
2.8M
-66.67%
8.5M
N/A
Total Liabilities
10.4M
+330.86%
2.4M
-75.44%
9.9M
+19.26%
8.3M
N/A
Retained Earnings
-130.4M
+43.80%
-90.7M
-2.97%
-93.5M
+16.46%
-80.3M
N/A
Total Stockholders Equity
-1.3M
-107.63%
16.5M
+339.30%
3.8M
+378.48%
-1.3M
N/A
Total Shares Outstanding
2.2M
-93.42%
32.7M
+73.09%
18.9M
+120.13%
8.6M
N/A
Cash Flow
Cash from Operating Activities
-28.1M
+3.45%
-27.2M
+150.67%
-10.8M
-36.34%
-17.0M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
1,981
0.00%
1,981
N/A
Cash from Investing Activities
-702
+1.30%
-693
-48.63%
-1,349
-31.90%
-1,981
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
20.9M
-24.86%
27.9M
+57.06%
17.7M
+173.28%
6.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-282.76%
-1,755.05%
17.08%
+113.28%
-128.63%
N/A
N/A
N/A
Return on Equity
-521.61%
-1,999.70%
27.46%
+102.50%
-1,098.51%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.88
-89.65%
8.52
+485.25%
1.46
N/A
N/A
N/A
Cash Ratio
0.59
-90.19%
5.99
+344.66%
1.35
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow